Giacomo di Nepi started his career in his homeland Italy with FIAT and McKinsey from where he transitioned to Novartis, where he held senior roles on different continents. After leaving Novartis he took on the role of CEO of Takeda Europe. He was then EVP and Managing Director, Europe of InterMune prior joining Polyphor in 2016. He is also in the Board of Geneuro and Kuros and a shareholders’ advisor for NTC. In 2016, Giacomo di Nepi became CEO of Polyphor, a clinical stage biopharmaceutical company based in Allschwil. The biotech is focused on the discovery and development of antibiotics and other specialty pharma products for severe or life-threatening diseases.